Clinical Trial Update: Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating parenteral amantadine for perioperative care in Parkinson disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• amantadine (amantadine)

Snippet

Sponsor: Rabin Medical Center | Conditions: Parkinson Disease, Perioperative Care | Phase 2 | Status: TERMINATED